WINDTREE THERAPEUTICS INC

Company snapshot

Windtree Therapeutics, Inc. (NasdaqCM: WINT) is a diversified company with several divisions, including a cryptocurrency treasury strategy and two promising therapeutic pipelines for which the Company is actively seeking long-term development partners. For more company information, please visit https://windtreetx.com/.

• 15 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 US patent(s) indexed to this assignee profile.
• 15 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for WINDTREE THERAPEUTICS INC. Not investment advice.

• Peer + 0 momentum

  Quantum Pharmaceuticals

  TA overlap score 23.6

• Peer + 0 momentum

  Arcturus Therapeutics

  TA overlap score 22.6

• Peer + 0 momentum

  Corbus Pharmaceuticals

  TA overlap score 22.2

Recent activity

Latest pipeline, patent, and corporate events for WINDTREE THERAPEUTICS INC.

1. Jun 8, 2026 Clinical update

   Istaroxime, LActose — Phase 2

2. Jun 8, 2026 Clinical update

   Lucinactant for Inhalation — Phase 2

3. Jun 8, 2026 Clinical update

   Lucinactant for inhalation — Phase 2

4. Jun 8, 2026 Clinical update

   Lucinactant — Phase 2

5. Jun 8, 2026 Clinical update

   A.1 Lucinactant — Phase 2

View all clinical trial activity →

• What is WINDTREE THERAPEUTICS INC?

  Windtree Therapeutics is a biotech organization headquartered in Warrington, USA. It trades on NYSE under ticker WINT. Primary therapeutic focus areas include Respiratory Distress Syndrome, Cardiogenic Shock, Respiratory Distress Syndrome, Newborn, Hypertension, Acute Respiratory

• Is WINDTREE THERAPEUTICS INC publicly traded?

  Yes. WINDTREE THERAPEUTICS INC is listed with ticker WINT on NYSE per SEC EDGAR records linked on this profile.

• What drugs does WINDTREE THERAPEUTICS INC develop or market?

  We link 9 drug profile(s) where WINDTREE THERAPEUTICS INC is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/windtree-therapeutics-inc-de#company-drugs.

• What are the latest developments for WINDTREE THERAPEUTICS INC?

  In the last 12 months our linked public records show 15 trial program update(s) and 1 US patent grant(s) tied to this profile.

• What therapeutic areas does WINDTREE THERAPEUTICS INC focus on?

  WINDTREE THERAPEUTICS INC focuses on Respiratory Distress Syndrome, Cardiogenic Shock, Respiratory Distress Syndrome, Newborn based on our analysis of their pipeline programs and drug development activities.